F18.980
Inhalant use, unspecified with inhalant-induced anxiety disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
Inhalant use refers to the inhalation of chemical vapors or fumes for their psychoactive effects. When this usage leads to anxiety symptoms directly caused by inhalant consumption, it is classified as inhalant-induced anxiety disorder under ICD-10 code F18.980. This condition highlights the mental health challenges associated with inhalant abuse and emphasizes the importance of awareness and proper management. It is a significant concern among adolescents and young adults, but anyone using inhalants can be affected.
Causes & Symptoms
Clinical Causes: Experimentation with inhalant substances to achieve a quick 'high' Peer pressure and social influences encouraging inhalant use Availability of household products or chemicals that can be inhaled Psychological factors, such as stress, anxiety, or depression Lack of awareness about the risks associated with inhalant use Underlying substance use disorders or other mental health conditions
Key Symptoms: Anxious feelings or panic attacks Restlessness and agitation Difficulty concentrating Irritability or mood swings Physical symptoms like dizziness, headache, or nausea Episodes of fear or paranoia Possible memory impairment during or after inhalant use
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough medical and psychological evaluation by a healthcare professional. The clinician will inquire about inhalant usage history, observe mental health symptoms, and may perform physical examinations or laboratory tests to rule out other causes. The diagnosis of inhalant-induced anxiety disorder is made when anxiety symptoms are directly linked to recent inhalant use. It is essential to differentiate this condition from other anxiety disorders for appropriate treatment planning.
Treatment Protocols: Managing inhalant-induced anxiety disorder typically includes a combination of approaches such as:
Clinical Advice & FAQs
Billing Guidance
Is F18.980 a billable ICD-10 code?
Yes, F18.980 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.980?
Clinical documentation must specify the nature of Inhalant use, unspecified with inhalant-induced anxiety disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference